Honokiol alleviates LPS-induced acute lung injury by inhibiting NLRP3 inflammasome-mediated pyroptosis via Nrf2 activation in vitro and in vivo

BACKGROUND: Honokiol (HKL) has been reported to ameliorate lipopolysaccharide (LPS)-induced acute lung injury (ALI). However, its potential mechanism of its protective effects remains unclear. In this study, the protective mechanism of HKL on LPS-induced ALI was explored in vivo and in vitro. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yuhan, Zhou, Jiabin, Luo, Yingying, Li, Jinxiao, Shang, Luorui, Zhou, Fangyuan, Yang, Shenglan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628413/
https://www.ncbi.nlm.nih.gov/pubmed/34844623
http://dx.doi.org/10.1186/s13020-021-00541-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628413/
https://www.ncbi.nlm.nih.gov/pubmed/34844623
http://dx.doi.org/10.1186/s13020-021-00541-z

Ejemplares similares